March 2025

EMA’s New Clinical Trial Map: Transforming Access and Transparency in European Clinical Research

The new Clinical Trial Map, made available by the European Medicines Agency (EMA) through the public online platform CTIS, represents a particularly significant advancement in the field of clinical research in Europe. This innovative and effective tool enables patients and healthcare professionals to identify, in real-time, ongoing clinical trials across Europe by geographic region and […]

EMA’s New Clinical Trial Map: Transforming Access and Transparency in European Clinical Research Read More »

Clinical Trials in Greece: A Strategic Opportunity for Patients and Investment

Clinical Trials in Greece:: A Strategic Opportunity for Patients and Investment

At the joint session of the Hellenic Parliament’s Special Permanent Committee on Research and Technology and the Standing Committee on Social Affairs on “Clinical Trials in Greece” (21 March 2025), HACRO President Evangelia (Lia) Koraki underlined the dual value of clinical research: improving patients’ access to innovative treatments while strengthening Greece’s position as an attractive

Clinical Trials in Greece: A Strategic Opportunity for Patients and Investment Read More »